lncRNA TUG1 inhibits the cancer stem cell-like properties of temozolomide-resistant glioma cells by interacting with EZH2

Temozolomide (TMZ) is currently one of the first-line drugs used for the treatment of high-grade gliomas. However, TMZ resistance results in unsatisfactory therapeutic effects in gliomas. Cancer stem cells (CSCs) have recently been determined to serve a pivotal regulatory role in tumor metastasis, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yiqiang, Chai, Wenying, Wang, Yonggang, Tang, Dang, Shao, Dongchuan, Song, Hai, Long, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170197/
https://www.ncbi.nlm.nih.gov/pubmed/34036375
http://dx.doi.org/10.3892/mmr.2021.12172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170197/
https://www.ncbi.nlm.nih.gov/pubmed/34036375
http://dx.doi.org/10.3892/mmr.2021.12172

Ejemplares similares